Financials
Income statement
| Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|
| Total reported revenue | 14.4B | 13.1B | 13.3B | 13.3B |
| Cost of revenue | 11.5B | 10.5B | 10.5B | 10.4B |
| Gross profit | 2.8B | 2.7B | 2.9B | 2.9B |
| Operating expense | ||||
| Research & development | 503M | 370M | 403M | 395M |
| Selling general and admin | 1.5B | 1.5B | 1.3B | 1.4B |
| Other operating expenses | 178M | 90M | 62M | 67M |
| Operating income | 826M | 909M | 1.2B | 1.2B |
| Non operating interest income | ||||
| Income | 110M | 120M | 96M | 104M |
| Expense | 212M | 50M | 39M | 48M |
| Other income expense | — | — | — | — |
| Pretax income | 538M | 943M | 1.1B | 1.2B |
| Tax provision | -265M | 316M | 344M | 341M |
| Net income | 803M | 627M | 789M | 847M |
| Basic EPS | — | 0.8 | 0.9 | 1 |
| Diluted EPS | — | 0.8 | 0.9 | 1 |
| Basic average shares | — | 793M | 803M | 804M |
| Diluted average shares | — | 793M | 803M | 804M |
| EBITDA | 1.1B | 1.3B | 1.5B | 1.5B |
| Net income from continuing op. | 538M | 944M | 1.1B | 1.2B |
| Minority interests | -56M | -17M | -47M | -47M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |